TenAces Biosciences

Developing rationally designed molecular glue therapeutics using a data-centric approach and machine learning.

Health Tech & Life Sciences
Active
Seed Rehovot, Israel Founded 2023
LinkedIn
Last updated 2026-07-26
Total raised
Last: Undisclosed Round 2024-01
Stage
Seed
Founded
2023
Headcount
6
HQ
Rehovot, Israel
Sector
Health Tech & Life Sciences

About

TenAces Biosciences is an Israeli startup focused on developing novel molecular glue therapies. The company leverages machine learning and a data-centric approach to predict and design new molecular glues, aiming to improve the success rate of discovering treatments for a range of conditions, particularly addressing the 85% of target proteins currently considered undruggable. TenAces emerged from AION Labs' fifth startup challenge and integrates biology into its machine learning algorithms with wet lab validations to enhance predictive capabilities.

Funding history · 1 round · — total

2023-12
Undisclosed Round Undisclosed
★ AION Labs★ Israel Biotech Fund

Headcount over time

From 3 (2024-01) to 4 (2026-03) · +1 (+33%) · 5 points · source: Finder history + radar grounding
70 2024-01 2026-03

Q&A

What is TenAces Biosciences' primary focus?
TenAces Biosciences is an Israeli startup focused on developing novel molecular glue therapies using a data-centric approach and machine learning.
When was TenAces Biosciences founded?
TenAces Biosciences was founded in 2023.
How many employees does TenAces Biosciences currently have?
TenAces Biosciences has 6 employees, falling within the 1-10 employee bucket.
What is the total amount of funding TenAces Biosciences has raised to date?
TenAces Biosciences has raised a total of $1,000,000 USD.
What was TenAces Biosciences' most recent funding round?
TenAces Biosciences completed a Seed round in January 2024.
What technologies does TenAces Biosciences leverage in its operations?
TenAces Biosciences leverages Artificial Intelligence, Machine Learning, Biologicals, and Molecules in its operations.
Who are the co-founders of TenAces Biosciences?
The co-founders of TenAces Biosciences are Arnout Schepers, who serves as CEO, and Tomer Sidi, who is the Chief AI Officer.
From which program did TenAces Biosciences emerge?
TenAces Biosciences emerged from AION Labs' fifth startup challenge.

Team · 3

Arnout Schepers
Founder · CEO & Co-Founder
Tomer Sidi
Founder · Chief AI Officer
Chen Lior
Founder · Bioinformatics Lead

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Artificial IntelligenceMachine LearningBiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Tags

machine-learningpharmaceuticalscell-therapybiopharmaceutical
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

LinkedInlinkedin.com/company/100609564

Identifiers & details

Legal nameTenAces Biosciences Ltd
Founded2023
Employees (exact)6

Radar intelligence

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)516856499
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2023-08-14
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2026
Active charges / liens0
Registry events2 — violation (1), annual_report (1)
Registered addressאופנהיימר 4 רחובות

Recent registry events

DateEvent
2026-05-27עדכון הפרה
2026-05-26דו~ח שנתי